Genome Biology

official impact factor 6.89

Open Access Research

Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus

Christoph Welsch1,2,3*, Francisco S Domingues1, Simone Susser2,3, Iris Antes1, Christoph Hartmann1, Gabriele Mayr1, Andreas Schlicker1, Christoph Sarrazin2,3, Mario Albrecht1, Stefan Zeuzem2,3 and Thomas Lengauer1

Author Affiliations

1 Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, 66123 Saarbrücken, Germany

2 Department of Internal Medicine I, Johann Wolfgang Goethe University Hospital, 60590 Frankfurt/Main, Germany

3 Department of Internal Medicine II, Saarland University Hospital, 66421 Homburg/Saar, Germany

For all author emails, please log on.

Genome Biology 2008, 9:R16 doi:10.1186/gb-2008-9-1-r16

Published: 23 January 2008

Additional files

Additional data file 1:

Figure S1 illustrates NS3-4A protease-ligand interactions. Figure S2 shows the complete network of non-covalent, H-bond and van der Waals, interactions of the NS3-4A protease for the PDB entry 1RTL. Figure S3 gives results of SCH 503034 and VX-950 inhibitor studies using an HCV V36G mutant replicon assay. Table S1 lists HCV genotypes included into the multiple sequence alignment of Figure 9.

Format: PDF Size: 4.8MB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data